Georgina Fraser, Ph.D. +44(20)7552-5984 | georgina.fraser@gs.com Goldman Sachs International 17 August 2026 | 8:03AM GST Equity Research Novonesis (NSISb.CO): 2Q26 Preview: Beat expected (+170bps OSG vs. Cons) into more cautious investor sentiment; reiterate Buy (on CL) Novonesis will release 2Q26 results on 20 August. We anticipate solid results (9.5% OSG vs. Cons at 7.7%; 37.6% adj. EBITDA margin vs. Cons at 37.8%), but note incremental cautiousness in recent client conversations around tougher comparable ...